In the Press

Published December 9, 2015 in The Baltimore Sun. The University of Maryland, Baltimore has given a Baltimore-based biotech company worldwide, exclusive licensing rights to the university’s patents and technology to develop a faster, cheaper way to identify dangerous pathogens, University …

Published May 15, 2015 in Ag Professional. On April 30, 2015, KeyGene USA, celebrated the opening of its new R&D facilities co-located at the University of Maryland’s Institute for Bioscience and Biotechnology Research (IBBR) in Rockville, Maryland. The R&D facilities include offices, …

Biomecite Diagnostics is commercializing a tool that uses genetics to detect gastrointestinal diseases.

Published May 7, 2015 on UMB News. There is nothing like the sight of children to inspire hope, so it was only fitting that University of Maryland, Baltimore (UMB) President Jay A. Perman, MD, began his second annual State of …

Published May 7, 2015 in IBD News. The University of Maryland (UM) Ventures has established an agreement with Biomecite Diagnostics, LLM, giving the company the exclusive option for the rights to developing novel methods for diagnosing inflammatory bowel diseases (IBD) from …

Published April 24, 2015 in BioPharma Reporter. US researchers have discovered the most precise method yet for measuring the structure of monoclonal antibodies.   The technique gives manufacturers and regulators a way of assessing and comparing the performance and quality of …

New audio technologies could radically change the way we play games, listen to music and experience movies.

It’s said to be the world’s first “out-of-hospital” artificial lung. The University of Maryland’s commercialization arm is backing the venture.

Published April 15, 2015 in Phys.org. A schematic showing the NISTmAb monoclonal antibody, an immunoglobulin G (IgG) molecule being developed by NIST as a reference material. The labels mark the fragments Fab and Fc that were used in the novel …